Navigation Links
GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
Date:10/24/2008

confirms the uniqueness of our proprietary technology as well as the global leadership of our company's platform in the protein therapeutics optimization arena. There is potential to apply our technology to additional important classes of therapeutic cytokines such as Interleukins and CSFs," added Dr. Escary, chief executive officer.

The company's first lead product is a novel, natural human IFN alpha variant protein called GEA007.1, a protein which is found in all major human populations It is a naturally occurring variant of human IFN alpha 17, which incorporates an innovative amino acid substitution G45R that provides a novel positive charge together with a change in 3-D structure of the protein receptor binding site. The biochemical and structural modifications induced in the protein binding site provide for superior anti-HCV efficacy using the industry gold standard replicon assay without significantly increased toxicity as demonstrated in Rhesus Monkeys compared to standards of care IFN alpha 2 molecules. GEA007.1 product patent applications have been granted in the EU and in the USA and are pending in an additional 17 countries including Japan and emerging countries like China where HCV is also a major health problem.

Examination procedures by the international patent offices have not revealed any relevant prior art to such product or to the natural evolution technology invented by the company.

About GenOdyssee S.A.

GenOdyssee applies its proprietary population-genetics-based drug discovery approach using a proprietary DNA databank representative of more than 90% of the different ethnicities that constitute the current human population, which is screened for natural genetic variants of therapeutic proteins with superior pharmacological properties. The company pioneered the vision that natural evolution has led to the generation in the current population of unpredictable mutations that confer superior or novel therapeutic status to
'/>"/>

SOURCE GenOdyssee SA
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2. Alfacell Receives Going Concern Audit Opinion
3. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
4. NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device
5. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
6. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
7. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
8. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
Breaking Biology News(10 mins):Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Genome BC collaborates with Chile and Norway to sequence salmon genome 2Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 1Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 3Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 4Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 5Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 6Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 7Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 8Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 9Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 10Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 11Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 12Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 13Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 14Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 15Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 16Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 17Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 18Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 19Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 20Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 21Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 22Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 23Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 24Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 25Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 26Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 27Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 1Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 2Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 3Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 4Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 5Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 6Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 7Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 8Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 9Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 10Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 11Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 12Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 13Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 14